Raymond James & Associates First Trust Nyse Arca Biotechn Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

A detailed history of Raymond James & Associates transactions in First Trust Nyse Arca Biotechn stock. As of the latest transaction made, Raymond James & Associates holds 77,934 shares of FBT stock, worth $12.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

77,934

Previous 80,158 2.77%

Holding current value

$12.6 Million

Previous $12.3 Million 8.56%

% of portfolio

0.01%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$152.39 - $172.91 $338,915 - $384,551	-2,224 Reduced 2.77%	77,934 $13.4 Million
Q2 2024 Jul 19, 2024	SELL	$141.52 - $156.4 $4.39 Million - $4.85 Million	-31,041 Reduced 27.91%	80,158 $12.3 Million
Q1 2024 Apr 22, 2024	SELL	$145.08 - $160.46 $2.01 Million - $2.23 Million	-13,879 Reduced 11.1%	111,199 $17.1 Million
Q4 2023 Jan 16, 2024	SELL	$132.5 - $158.45 $65,587 - $78,432	-495 Reduced 0.39%	125,078 $19.8 Million
Q3 2023 Oct 24, 2023	SELL	$145.69 - $157.89 $921,926 - $999,127	-6,328 Reduced 4.8%	125,573 $18.4 Million
Q2 2023 Jul 25, 2023	SELL	$151.19 - $159.79 $2.87 Million - $3.03 Million	-18,956 Reduced 12.57%	131,901 $20.2 Million
Q1 2023 Apr 14, 2023	BUY	$147.92 - $165.37 $240,813 - $269,222	1,628 Added 1.09%	150,857 $23.4 Million
Q4 2022 Feb 08, 2023	BUY	$132.87 - $159.04 $3.98 Million - $4.77 Million	29,981 Added 25.14%	149,229 $23 Million
Q3 2022 Oct 25, 2022	BUY	$128.6 - $149.75 $1.07 Million - $1.25 Million	8,326 Added 7.51%	119,248 $15.7 Million
Q2 2022 Aug 12, 2022	SELL	$123.32 - $155.54 $1.1 Million - $1.39 Million	-8,908 Reduced 7.43%	110,922 $15 Million
Q1 2022 May 11, 2022	SELL	$137.27 - $163.07 $1.94 Million - $2.31 Million	-14,143 Reduced 10.56%	119,830 $17.9 Million
Q4 2021 Feb 08, 2022	SELL	$153.09 - $169.84 $2.4 Million - $2.66 Million	-15,688 Reduced 10.48%	133,973 $21.7 Million
Q3 2021 Nov 02, 2021	SELL	$164.82 - $176.04 $3.19 Million - $3.41 Million	-19,357 Reduced 11.45%	149,661 $24.9 Million
Q2 2021 Aug 11, 2021	SELL	$157.67 - $176.2 $5.96 Million - $6.66 Million	-37,819 Reduced 18.28%	169,018 $29.2 Million
Q1 2021 May 14, 2021	SELL	$156.06 - $184.84 $2.56 Million - $3.03 Million	-16,390 Reduced 7.34%	206,837 $33.2 Million
Q4 2020 Feb 12, 2021	SELL	$152.75 - $174.52 $363,545 - $415,357	-2,380 Reduced 1.05%	223,227 $37.5 Million
Q3 2020 Nov 04, 2020	BUY	$150.39 - $180.07 $754,506 - $903,411	5,017 Added 2.27%	225,607 $35.5 Million
Q2 2020 Jul 28, 2020	BUY	$127.11 - $171.8 $5.23 Million - $7.07 Million	41,179 Added 22.95%	220,590 $37 Million
Q1 2020 Apr 21, 2020	BUY	$114.56 - $156.02 $1.91 Million - $2.6 Million	16,688 Added 10.26%	179,411 $23.5 Million
Q4 2019 Feb 12, 2020	SELL	$120.34 - $154.01 $1.04 Million - $1.34 Million	-8,673 Reduced 5.06%	162,723 $24.2 Million
Q3 2019 Nov 07, 2019	SELL	$123.44 - $131.99 $24.4 Million - $26 Million	-197,324 Reduced 53.52%	171,396 $21.2 Million
Q2 2019 Aug 06, 2019	BUY	N/A	31,046 Added 9.19%	368,720 $51.9 Million
Q1 2019 May 06, 2019	BUY	N/A	32,363 Added 10.6%	337,674 $50.9 Million
Q4 2018 Feb 11, 2019	BUY	N/A	2,695 Added 0.89%	305,311 $37.9 Million
Q3 2018 Nov 14, 2018	BUY	N/A	158,596 Added 110.12%	302,616 $48 Million
Q2 2018 Aug 14, 2018	BUY	N/A	14,642 Added 11.32%	144,020 $20.2 Million
Q1 2018 May 14, 2018	BUY	N/A	26,131 Added 25.31%	129,378 $17.2 Million
Q4 2017 Feb 14, 2018	BUY	N/A	2,763 Added 2.75%	103,247 $12.9 Million
Q3 2017 Nov 13, 2017	BUY	N/A	23,389 Added 30.34%	100,484 $12.5 Million
Q2 2017 Aug 14, 2017	BUY	N/A	77,095	77,095 $8.79 Million

Others Institutions Holding FBT

# of Institutions

297

Shares Held

3.78M

Call Options Held

14K

Put Options Held

200

View Full List

About FIRST TRUST NYSE ARCA BIOTECHN

Ticker FBT
Sector ETFs
Industry ETFs

More about FBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates First Trust Nyse Arca Biotechn Transaction History